- Providing strategic policy and regulatory counsel on a broad range of drug and device pricing and reimbursement matters, including the Medicaid Drug Rebate Program, Medicare Parts B and D, government procurement, and importation.
- Counseling hospitals and other covered entities on 340B Drug Pricing Program matters, including compliance, audit preparation and response, and policy developments.
- Advising health care clients on surprise billing, price transparency, COVID-19 response, and other emerging legislative and regulatory policy developments.
- Providing strategic counsel on advocacy efforts on emerging health care policy issues, including the development of comment letters and assistance with outreach to congressional and agency staff.
- Assisting life sciences and provider clients with development of innovative payment models.
- Providing legislative and regulatory counsel to several biopharmaceutical companies on matters such as biosimilar development, rare disease therapies, and patient assistance programs.
- Counseling on HIPAA, Part 2, GINA, GDPR, and other international, federal, and state privacy laws.
- Providing regulatory counsel for securities filings, mergers and acquisitions, and other transactional matters.
Senior Associate,
- Phone: +1 202 239 3768
- Email: emily.shaw@alston.com
Emily offers sound and strategic counsel to clients on transactional, regulatory, and legislative issues.